Unraveling the proteomic landscape of red-fleshed apples to identify regulators of anthocyanin accumulation
- PMID: 40472891
- DOI: 10.1016/j.jprot.2025.105470
Unraveling the proteomic landscape of red-fleshed apples to identify regulators of anthocyanin accumulation
Abstract
Anthocyanins are colorful plant pigments with antioxidant properties, and a diet rich in these flavonoids bears health benefits. Therefore, a strong anthocyanin accumulation in edible plant parts is of significant interest, and in Malus domestica, the domesticated apple, certain red-fleshed apple varieties exhibit this trait. Enhanced anthocyanin accumulation in the flesh of apple fruits is attributed to the hyperactivation of the MYB transcription factor MdMYB10, which acts as a key regulator of anthocyanin biosynthesis by inducing the expression of multiple biosynthetic genes. While several studies have explored the underlying genetic mutations and resulting transcriptome changes, there is a lack of research on proteome alterations that cause the red-fleshed apple phenotype. To address this gap, a mass spectrometry-based proteomics approach was employed. Comparative proteomics identified differentially abundant proteins in young and mature fruits of the red-fleshed 'Bay13645' variety compared to the white-fleshed 'Gala'. Whereas several MYB transcription factors were enriched during early fruit development, they were no longer among the hyper-abundant proteins in ripe fruits of the red-fleshed genotype. In contrast, anthocyanin biosynthetic enzymes were enriched more strongly in ripe fruits of the red-fleshed cultivar, supporting previous results which had indicated developmental stage-specific differences in the control of the pigmentation process. The proteomic approach also identified novel regulatory factors and enzymes that may contribute to the red-fleshed apple phenotype, including a BAHD acyltransferase, Mal d proteins, and transcription factors of diverse families, and their potential relevance for the exhibition of this trait is discussed. SIGNIFICANCE: This study offers insights into the molecular mechanisms driving anthocyanin accumulation in red-fleshed apples. Utilizing a mass spectrometry-based proteomics strategy, the study reveals proteome alterations during fruit development that underlie the red-fleshed phenotype in Malus domestica. Notably, key enzymes of anthocyanin biosynthesis were markedly upregulated, underscoring their role in the pigmentation of the apple fruit pulp. Importantly, the study also identifies previously uncharacterized proteins, including a BAHD acyltransferase and a suite of transcription factors, shedding new light on the regulatory network orchestrating anthocyanin accumulation. These findings significantly expand our understanding of metabolic pathways that contribute to fruit pigmentation and open promising avenues for targeted crop improvement.
Keywords: Acyltransferase; Fruits; MYB transcription factors; Mal d proteins; Malus domestica.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest.
Similar articles
-
Epigenetic Silencing of MsMYB1R1 Drives Anthocyanin Reduction in Developing Red-Fleshed Apple.J Agric Food Chem. 2025 Jun 25;73(25):15550-15560. doi: 10.1021/acs.jafc.5c02314. Epub 2025 Jun 12. J Agric Food Chem. 2025. PMID: 40504813
-
MdLBD37 and MdBZR1 inhibit anthocyanin biosynthesis in apple under high temperature.Plant Sci. 2025 Oct;359:112621. doi: 10.1016/j.plantsci.2025.112621. Epub 2025 Jun 24. Plant Sci. 2025. PMID: 40571103
-
Red colouration in apple fruit is due to the activity of the MYB transcription factor, MdMYB10.Plant J. 2007 Feb;49(3):414-27. doi: 10.1111/j.1365-313X.2006.02964.x. Epub 2006 Dec 20. Plant J. 2007. PMID: 17181777 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous